ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

1SAN Sanofi

89.75
1.57 (1.78%)
2024年6月1日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Sanofi 1SAN イタリア Ordinary Share
  前日比 前日比 % 現在値 時刻
1.57 1.78% 89.75 00:30:05
始値 安値 高値 終値 前日終値
88.10 87.97 89.75 89.75 88.18
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/3119:00GLOBECommuniqué de presse : Sanofi lance son plan mondial 2024..
2024/5/3114:05GLOBECommuniqué de presse : Le CHMP recommande l'approbation de..
2024/5/3114:00GLOBEPress Release: Update on FDA priority review of Dupixent for..
2024/5/3022:01GLOBECommuniqué de presse : Sanofi finalise l’acquisition..
2024/5/2714:00GLOBEPress Release: Sarclisa accepted for FDA priority review for..
2024/5/2114:30GLOBECommuniqué de presse : Sanofi, Formation Bio et OpenAI..
2024/5/2105:54GLOBESanofi: Informations relatives au nombre de droits de vote..
2024/5/2103:15GLOBEPress Release: Dupixent® late-breaking data from NOTUS..
2024/5/1314:00GLOBEPress Release: Sanofi adds over €1 billion for..
2024/5/1015:00GLOBECommuniqué de presse : Sanofi et Novavax concluent un accord..
2024/5/0214:00GLOBEPress Release: Beyfortus real-world evidence published in..
2024/5/0101:00GLOBEPress Release: Annual General Meeting of April 30, 2024
2024/4/2514:30GLOBEPress Release: Sanofi Q1: robust 7% sales growth driven by..
2024/4/2314:00GLOBEPress Release: Rilzabrutinib LUNA 3 phase 3 study met..
2024/4/1714:00GLOBEPress Release: New 48-week frexalimab phase 2 data support..
2024/4/1303:05GLOBESanofi: Information concerning the total number of voting..
2024/4/0901:00GLOBESanofi - AGM 30.04.2024 - Availability of Preparatory..
2024/3/2215:30GLOBEPress Release: Availability of the Q1 2024 Memorandum for..
2024/3/1604:04GLOBESanofi: Informations relatives au nombre de droits de vote..
2024/3/1115:00GLOBEPress Release: New Phase 2b results for amlitelimab support..
2024/2/2423:51GLOBEPress Release: Phase 2 results demonstrate rilzabrutinib..
2024/2/2402:45GLOBEPress Release: Filing of the 2023 U.S. Form 20-F and French..
2024/2/2315:00GLOBEPress Release: Dupixent® sBLA accepted for FDA Priority..
2024/2/2303:02GLOBEPress Release: Sanofi’s Board of Directors proposes the..
2024/2/2107:40GLOBESanofi: Informations relatives au nombre de droits de vote..
2024/2/1615:00GLOBECommuniqué de presse : Le Japon est le premier pays dans le..
2024/2/1522:00GLOBECommuniqué de presse : Des données de phase II publiées dans..
2024/2/0516:00GLOBECommuniqué de presse : Entraide, conditions de travail..
2024/2/0115:30GLOBEPress Release: Sanofi Delivers Solid Sales and Business EPS..
2024/1/2604:30GLOBEPress Release: Dupixent® FDA approved as first and only..
2024/1/2315:30GLOBEPress Release: Sanofi to acquire Inhibrx, Inc., adding..
2024/1/1806:57GLOBESanofi: Informations relatives au nombre de droits de vote..
2024/1/0915:30GLOBEPress Release: Brian Foard appointed Head of Specialty Care..
2023/12/2115:30GLOBECommuniqué de presse : Sanofi annonce la fin du programme..
2023/12/1905:59GLOBESanofi: Information concerning the total number of voting..
2023/12/1515:30GLOBEPress Release: Availability of the Q4 2023 Memorandum for..
2023/12/1515:00GLOBEPress Release: EMA gives positive opinion to Fexinidazole..
2023/12/1206:08GLOBEPress Release: Statement on FTC challenge to proposed..
2023/12/1109:30GLOBEPress Release: Sarclisa® (isatuximab) plus KRd significantly..
2023/12/0715:35GLOBEPress Release: Sarclisa® (isatuximab) Phase 3 trial met..
2023/12/0711:30GLOBECommuniqué de presse : Sanofi sur la voie du leadership..
2023/11/2715:30GLOBEPress Release: Dupixent® significantly reduced COPD..
2023/11/2402:00GLOBESanofi: Information concerning the total number of voting..
2023/10/2714:31GLOBECommuniqué de presse : Un troisième trimestre solide, marqué..
2023/10/2714:30GLOBEPress Release: Sanofi Enters Next Chapter of Play to Win..
2023/10/2304:00GLOBEPress Release: Dupixent® (dupilumab) Phase 3 Results show..
2023/10/1919:00GLOBECommuniqué de presse : Sanofi livre les premiers médicaments..
2023/10/1817:45GLOBEPress Release: TZIELD® Phase 3 data presented at ISPAD shows..
2023/10/1803:18GLOBESanofi: Informations relatives au nombre de droits de vote..
2023/10/1323:00GLOBECommuniqué de presse : Des données de phase IIb de dernière..

最近閲覧した銘柄

Delayed Upgrade Clock